Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.08
- Piotroski Score 2.00
- Grade Neutral
- Symbol (KOD)
- Company Kodiak Sciences Inc.
- Price $2.65
- Changes Percentage (1.73%)
- Change $0.05
- Day Low $2.63
- Day High $2.75
- Year High $7.77
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $15.00
- High Stock Price Target $114.00
- Low Stock Price Target $2.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.44
- Trailing P/E Ratio -0.65
- Forward P/E Ratio -0.65
- P/E Growth -0.65
- Net Income $-260,491,000
Income Statement
Quarterly
Annual
Latest News of KOD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Sister Wives' Janelle Brown has bold opinion on Kody and Robyn's parenting
Sister Wives star Janelle Brown criticizes ex-husband Kody Brown's parenting on the reality TV show. Janelle expressed concerns about Kody and his wife Robyn's handling of their daughter's emotions wh...
By Newsweek | 3 days ago -
'Sister Wives': Kody Claims He Wasn't 'Going to Leave' Christine, Janelle and Meri 'No Matter How Much I Didn't Love Them'
Kody reflects on his failed marriage with Meri Brown on Sister Wives, acknowledging lack of wisdom and communication. Meri seeks formal release from their 32-year marriage, Kody struggles with church ...
By PEOPLE.com | 1 week ago -
Mets won't get Kodai Senga back for regular season but hold out hope for October
Kodai Senga of the New York Mets won't be back for the regular season due to tricep tightness. He aims to return in October if the team reaches the playoffs. Despite his absence, the Mets are fighting...
By The New York Times | 1 week ago
